Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1450 of 3546 entries
View as:

Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01431950 Org: User:
Start: 09/30/11 End: 10/31/12 Due: 10/31/13

A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT06734234 Org: User:
Start: 12/11/24 End: 08/13/26 Due: 08/13/27

Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety

Phase: N/A Priority: Normal
NCT ID: NCT00263692 Org: User:
Start: 11/30/02 End: 09/30/04 Due: 09/30/05

Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT01462565 Org: User:
Start: 11/01/11 End: 11/08/12 Due: 11/08/13

A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol (FSC) 250/50 Microgram (mcg) Twice Daily (BID) in Adults and Adolescents With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01978119 Org: User:
Start: 11/06/13 End: 01/28/15 Due: 01/28/16

Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)

Phase: N/A Priority: Normal
NCT ID: NCT00812812 Org: User:
Start: 03/31/09 End: 02/28/11 Due: 02/28/12

Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02075619 Org: User:
Start: 03/24/14 End: 07/11/14 Due: 07/11/15

Study to Estimate the Disease Burden of Acute Rotavirus Gastroenteritis in Children < 5 Years in United Arab Emirates

Phase: N/A Priority: Normal
NCT ID: NCT01201252 Org: User:
Start: 07/31/09 End: 07/31/10 Due: 07/31/11

Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants

Phase: N/A Priority: Normal
NCT ID: NCT00779779 Org: User:
Start: 11/22/08 End: 08/26/09 Due: 08/26/10

Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00316173 Org: User:
Start: 03/31/05 End: 03/31/09 Due: 03/31/10

A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01489943 Org: User:
Start: 09/19/11 End: 11/10/11 Due: 11/10/12

The Effects of Potassium Nitrate in Reducing Dentinal Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT01587950 Org: User:
Start: 02/28/09 End: 04/30/09 Due: 04/30/10

Targeted Literature Review and Subject Interviews in Wiskott-Aldrich Syndrome (WAS)

Phase: N/A Priority: Normal
NCT ID: NCT03399461 Org: User:
Start: 01/24/18 End: 09/14/18 Due: 09/14/19

The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01879423 Org: User:
Start: 04/28/13 End: 06/06/13 Due: 06/06/14

Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years

Phase: N/A Priority: Normal
NCT ID: NCT01777321 Org: User:
Start: 06/17/13 End: 11/11/14 Due: 11/11/15

Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab

Phase: N/A Priority: Normal
NCT ID: NCT00240591 Org: User:
Start: 10/31/03 End: 06/30/10 Due: 06/30/11

GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV)

Phase: N/A Priority: Normal
NCT ID: NCT02666287 Org: User:
Start: 01/27/16 End: 06/03/16 Due: 06/03/17

A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00733980 Org: User:
Start: 10/02/08 End: 06/18/10 Due: 06/18/11

Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01475734 Org: User:
Start: 12/31/11 End: 07/31/12 Due: 07/31/13

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00312013 Org: User:
Start: 05/31/06 End: 07/31/09 Due: 07/31/10

SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS

Phase: N/A Priority: Normal
NCT ID: NCT00996840 Org: User:
Start: 10/16/09 End: 02/09/13 Due: 02/09/14

An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed

Phase: N/A Priority: Normal
NCT ID: NCT01583036 Org: User:
Start: 01/16/12 End: 04/17/12 Due: 04/17/13

Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00508261 Org: User:
Start: 08/01/07 End: 10/27/08 Due: 10/27/09

SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00361959 Org: User:
Start: 06/30/03 End: 02/28/06 Due: 02/28/07

REMS Retigabine Study

Phase: N/A Priority: Normal
NCT ID: NCT01938560 Org: User:
Start: 02/28/13 End: 05/31/13 Due: 05/31/14